Role of Monoclonal Antibody "Alemtuzumab" in the Treatment of Multiple Sclerosis

This article will review current treatment options for multiple sclerosis (MS) while keeping our primary focus on alemtuzumab, as it is now approved in more than 65 countries. From a pathophysiological point of view, MS is a disabling disease impacting a patient's life both physically and menta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cureus
Main Authors: Nosher, Sadia, Fuad, Sehrish, Mishra, Nupur, Alrashid, Zaid A, Rathod, Bindu, Mohan, Devyani, Basavanagowda, Deepak M, Kaur, Arveen, Heindl, Stacey E
Formato: Artigo
Idioma:Inglês
Publicado em: Cureus 2021
Assuntos:
Family/General Practice
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7948316/
https://ncbi.nlm.nih.gov/pubmed/33728194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13246
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados